Last reviewed · How we verify
Neu-P11
Neu-P11 (Piromelatine) is a novel melatonin receptor agonist and serotonin 5-HT2C receptor antagonist in development by Neurim Pharmaceuticals for mild Alzheimer's disease and primary insomnia. It has completed Phase 2 trials and is currently in Phase 3 for Alzheimer's disease. The drug shows promise in improving cognitive function and sleep quality.
At a glance
| Generic name | Neu-P11 |
|---|---|
| Also known as | Melatonin agonist, there are no other names |
| Sponsor | Neurim Pharmaceuticals Ltd. |
| Modality | Small molecule |
| Phase | Phase 2 |